Viewing Study NCT02701205


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-03-01 @ 9:57 AM
Study NCT ID: NCT02701205
Status: UNKNOWN
Last Update Posted: 2016-03-08
First Post: 2016-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Sponsor: Shanghai Celgen Bio-Pharmaceutical Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module